Letter by Gronda et al Regarding Article, "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial"

Affiliations

¹ UOC di Nefrolo- gia, Dialisi e Trapianto Renale dell'Adulto, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Milan, Italy (E.G.).
² Azienda Complesso Ospedaliero San Filippo Neri, Rome, Italy (F.C.).
³ Cardiologia Clinica e Riabilitativa, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy (G.Z.).

Comment

Edoardo Gronda et al. Circulation. 2022.

. 2022 Apr 19;145(16):e839-e840.

doi: 10.1161/CIRCULATIONAHA.121.057530. Epub 2022 Apr 18.

¹ UOC di Nefrolo- gia, Dialisi e Trapianto Renale dell'Adulto, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Milan, Italy (E.G.).
² Azienda Complesso Ospedaliero San Filippo Neri, Rome, Italy (F.C.).
³ Cardiologia Clinica e Riabilitativa, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy (G.Z.).

No abstract available

Comment on

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ, Carson P, Anand I, Doehner W, Haass M, Komajda M, Miller A, Pehrson S, Teerlink JR, Schnaidt S, Zeller C, Schnee JM, Anker SD. Packer M, et al. Circulation. 2021 Oct 19;144(16):1284-1294. doi: 10.1161/CIRCULATIONAHA.121.056824. Epub 2021 Aug 29. Circulation. 2021. PMID: 34459213 Free PMC article. Clinical Trial.